drugset

drugset / Trial / NCT00661297

Study Evaluating the Efficacy, Safety, and Reliability of Vardenafil

NCT00661297 ↗

Phase 3 Completed 523 enrolled Bayer GlaxoSmithKline · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

Study to investigate the efficacy and safety of Vardenafil

Timeline

Start: 2003-06
Primary completion: —
Completion: 2004-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vardenafil	Small molecule	10 mg	—

Indications